WO2023175476 - IN VITRO METHODS
National phase entry:
Publication Number
WO/2023/175476
Publication Date
21.09.2023
International Application No.
PCT/IB2023/052406
International Filing Date
13.03.2023
Title **
[English]
IN VITRO METHODS
[French]
MÉTHODES IN VITRO
Applicants **
HALEON CH SARL
Inventors
BONCHEVA BETTEX, Mila
BAKER, Mark B.
BIRNGRUBER, Thomas
HUMMER, Joanna
MOORE, David J.
ROPER, Clive S.
SINNER, Frank
Priority Data
22161997.6
14.03.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2179 | |
| EPO | Filing, Examination, Granting | 8713 | |
| Japan | Filing, Examination, Granting | 2183 | |
| South Korea | Filing, Examination, Granting | 2020 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
19,835
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to improved methods for characterising diffusion of compounds through the skin using open flow micro-perfusion (OFM) in conjunction with Diffusion Cell apparatus, particularly static Franz Diffusion cell (FDC). The methods are in vitro methods using ex vivo skin explants.[French]
La présente invention concerne des méthodes améliorées pour caractériser la diffusion transcutanée de composés à l'aide d'une microperfusion à flux ouvert (OFM) conjointement avec un appareil de type cellule de diffusion, en particulier une cellule de Franz statique (FDC). Les procédés sont des procédés in vitro utilisant des explants de peau ex vivo.